medi7734
mAbexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 26, 2016 (NCT02780674)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- medi7734
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04925934 | Phase 2 | Jun 24, 2021 | Horizon Therapeutics, LLC, Viela Bio |
| NCT04526912 | Phase 1 | Aug 28, 2020 | Viela Bio |
| NCT03817424 | Phase 1 | Dec 13, 2018 | Viela Bio |
| NCT02780674 | Phase 1 | Aug 26, 2016 | MedImmune |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Viela Bio | For profit | 3 | 3 | 2 | 2018 |
| Horizon Therapeutics, LLC | For profit | 1 | 0 | 1 | 2021 |
| MedImmune | For profit | 1 | 1 | 1 | 2016 |
3 organizations
Page 1 / 1